NCT00467870View on ClinicalTrials.gov

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

PHASE3CompletedINTERVENTIONAL
Enrollment

531

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
HypogonadismPrimary HypogonadismSecondary Hypogonadism
Interventions
DRUG

Testosterone Undecanoate 750 mg

DRUG

Testosterone Undecanoate 1000 mg

Trial Locations (1)

02421

Indevus Pharmaceuticals, Inc., Lexington

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY